EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research

Nauf Bou Antoun, Hiba-Tun-Noor Afshan Mahmood iD, Anthony J Walker, Helmout Modjtahedi iD, Richard P Grose iD, Athina-Myrto Chioni iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nauf Bou Antoun und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences Pharmacy and Chemistry, Department of Biomolecular Sciences, Kingston University London, Kingston-upon-Thames KT1 2EE, UK. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Drug Resistance, Neoplasm, Pyrimidines, Protein Kinase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary or acquired resistance to therapeutic agents is a major obstacle in the treatment of cancer patients. Cervical cancer is the fourth leading cause of cancer deaths among women worldwide and, despite major advances in cancer screening and treatments, many patients with advanced stage cervical cancer have a high recurrence rate within two years of standard treatment, with drug resistance being a major contributing factor. The development of cancer cell lines with acquired resistance to therapeutic agents can facilitate the comprehensive investigation of resistance mechanisms, which cannot be easily performed in clinical trials. This study aimed to create three novel and robust cervical cancer cell lines (HeLa, CaSki, and SiHa) with acquired resistance to a fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor (PD173074). All three drug-resistant (DR) cell lines overexpressed FGFR1, FGFR2, FGF2, FGF4, and FGF7 proteins that were also localized to the nucleus. In addition, the DR cells had a significantly more aggressive phenotype (more migratory and proliferative, less apoptotic) compared to the parental cell lines. These novel DR cervical cancer cells are a critical tool for understanding the molecular mechanisms underpinning drug resistance and for the identification of potential cervical cancer biomarkers. Moreover, the availability of such DR cell lines may facilitate the development of more effective therapeutic strategies using FGFR inhibitors in combination with other agents that target pathways responsible for acquired resistance to FGFR inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsDrug Resistance, NeoplasmPyrimidinesProtein Kinase InhibitorsReceptors, Fibroblast Growth FactorAntineoplastic AgentsHumansFemaleCell Line, TumorCell ProliferationApoptosisHeLa CellsCell Movement

Stichwörter der Autor:innen

CaSkiFGF(R)HeLaSiHacervical cancercervical cancer treatmentdrug resistance

Substanzen

PyrimidinesPD 173074Protein Kinase InhibitorsReceptors, Fibroblast Growth FactorAntineoplastic Agents

Autor:innen und Institutionen

  • School of Life Sciences Pharmacy and Chemistry, Department of Biomolecular Sciences, Kingston University London, Kingston-upon-Thames KT1 2EE, UK.
  • Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.

ORCID-Profile: Hiba-Tun-Noor Afshan Mahmood, Helmout Modjtahedi, Richard P Grose, Athina-Myrto Chioni

Zitieren

APA

Bou Antoun, N., Afshan Mahmood, H. T., Walker, A. J., Modjtahedi, H., Grose, R. P., & Chioni, A. M. (2025). Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051799

Vancouver

Bou Antoun N, Afshan Mahmood HT, Walker AJ, Modjtahedi H, Grose RP, Chioni AM. Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051799

BibTeX
@article{BouAntoun2025,
  author = {Bou Antoun, Nauf and Afshan Mahmood, Hiba-Tun-Noor and Walker, Anthony J and Modjtahedi, Helmout and Grose, Richard P and Chioni, Athina-Myrto},
  title = {Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051799}
}
Kostenlos starten →